185 related articles for article (PubMed ID: 26899498)
81. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.
Duman RS
Dialogues Clin Neurosci; 2009; 11(3):239-55. PubMed ID: 19877493
[TBL] [Abstract][Full Text] [Related]
82. Metabotropic glutamate receptors: targets for therapy of cerebral ischaemia.
Costantino G; Macchiarulo A; Pellicciari R
Expert Opin Ther Targets; 2001 Dec; 5(6):669-683. PubMed ID: 12540277
[TBL] [Abstract][Full Text] [Related]
83. Neuroprotective Cationic Arginine-Rich Peptides (CARPs): An Assessment of Their Clinical Safety.
Edwards AB; Mastaglia FL; Knuckey NW; Meloni BP
Drug Saf; 2020 Oct; 43(10):957-969. PubMed ID: 32613595
[TBL] [Abstract][Full Text] [Related]
84. Neuroprotection.
Lees KR
Br Med Bull; 2000; 56(2):401-12. PubMed ID: 11092089
[TBL] [Abstract][Full Text] [Related]
85. Excitotoxic Storms of Ischemic Stroke: A Non-neuronal Perspective.
Yang XM; Yu H; Li JX; Li N; Li C; Xu DH; Zhang H; Fang TH; Wang SJ; Yan PY; Han BB
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38662299
[TBL] [Abstract][Full Text] [Related]
86. Lubeluzole shows neuroprotective effects in an "in-vitro"-model for neuronal lesions in the chicken retina.
Wiedemann M; Hanke W
Brain Res; 1999 Sep; 842(1):243-8. PubMed ID: 10526119
[TBL] [Abstract][Full Text] [Related]
87. Extracellular ferritin contributes to neuronal injury in an in vitro model of ischemic stroke.
Gámez A; Alva N; Carbonell T; Rama R
J Physiol Biochem; 2021 Nov; 77(4):539-545. PubMed ID: 33829407
[TBL] [Abstract][Full Text] [Related]
88. Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis.
Pichardo-Rojas D; Pichardo-Rojas PS; Cornejo-Bravo JM; Serrano-Medina A
Front Neurosci; 2023; 17():1096372. PubMed ID: 36743806
[TBL] [Abstract][Full Text] [Related]
89. Potential molecular targets for translational stroke research.
Vosler PS; Chen J
Stroke; 2009 Mar; 40(3 Suppl):S119-20. PubMed ID: 19064800
[No Abstract] [Full Text] [Related]
90. Influencing neuroplasticity in stroke treatment with advanced biomaterials-based approaches.
Obermeyer JM; Ho E; Gracias A; Shoichet MS
Adv Drug Deliv Rev; 2019 Aug; 148():204-218. PubMed ID: 30579882
[TBL] [Abstract][Full Text] [Related]
91. New directions in neuroprotection: basic mechanisms, molecular targets and treatment strategies.
Refolo LM; Fillit HM
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S1-2. PubMed ID: 15665407
[No Abstract] [Full Text] [Related]
92. Neuroprotection against stroke and CNS injury: new mechanisms, targets, and controversies.
Leak RK; Chen J
CNS Neurol Disord Drug Targets; 2013 May; 12(3):300-1. PubMed ID: 23469857
[No Abstract] [Full Text] [Related]
93. Potential beneficial effects of marine peptide on human neuron health.
Ryu B; Kim SK
Curr Protein Pept Sci; 2013 May; 14(3):173-6. PubMed ID: 23721317
[TBL] [Abstract][Full Text] [Related]
94. Signalling pathways with small molecule mimetics and modulators to achieve neuroprotection and regeneration.
Skaper SD
CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):45. PubMed ID: 18289030
[No Abstract] [Full Text] [Related]
95. Apoptotic neuronal death following cerebral ischaemia.
Miles AN; Knuckey NW
J Clin Neurosci; 1998 Apr; 5(2):125-45. PubMed ID: 18639001
[TBL] [Abstract][Full Text] [Related]
96. Experimental neuronal protection in cerebral ischaemia Part II: Potential neuroprotective drugs.
Martin RL
J Clin Neurosci; 1997 Jul; 4(3):290-310. PubMed ID: 18638975
[TBL] [Abstract][Full Text] [Related]
97. Neuroprotection: Rescue from Neuronal Death in the Brain.
Lee BH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073797
[TBL] [Abstract][Full Text] [Related]
98. Cellular and molecular responses of cultured neurons to stressful stimuli.
Chen J; Pan H; Lipsky RH; Pérez-Gómez A; Cabrera-Garcia D; Fernández-Sánchez MT; Novelli A; Marini AM
Dose Response; 2011; 9(3):416-33. PubMed ID: 22013403
[TBL] [Abstract][Full Text] [Related]
99. Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.
Erdmann NB; Whitney NP; Zheng J
Clin Neurosci Res; 2006 Dec; 6(5):315-328. PubMed ID: 18059978
[TBL] [Abstract][Full Text] [Related]
100. Targeting the melanocortin receptor system for anti-stroke therapy.
Holloway PM; Smith HK; Renshaw D; Flower RJ; Getting SJ; Gavins FN
Trends Pharmacol Sci; 2011 Feb; 32(2):90-8. PubMed ID: 21185610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
